Skip to main content
logo

Remus Pharmaceuticals Limited (NSE:REMUS)

India flag India · Delayed Price · Currency is INR
683.50
-0.90 (-0.13%)
At close: Oct 13, 2025

Remus Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212020
Period Ending
Oct '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020
Market Capitalization
3,98413,19210,163---
Upgrade
Market Cap Growth
-74.84%29.81%----
Upgrade
Enterprise Value
4,20813,16410,212---
Upgrade
Last Close Price
683.501118.79861.04---
Upgrade
PE Ratio
13.8545.3849.53---
Upgrade
PS Ratio
0.642.134.77---
Upgrade
PB Ratio
1.414.675.80---
Upgrade
P/TBV Ratio
1.615.346.83---
Upgrade
P/FCF Ratio
132.80439.73----
Upgrade
P/OCF Ratio
57.08189.00752.80---
Upgrade
EV/Sales Ratio
0.682.124.80---
Upgrade
EV/EBITDA Ratio
9.2129.2535.56---
Upgrade
EV/EBIT Ratio
9.6030.0436.68---
Upgrade
EV/FCF Ratio
140.27438.80----
Upgrade
Debt / Equity Ratio
0.080.080.080.420.030.09
Upgrade
Debt / EBITDA Ratio
0.500.500.490.710.040.21
Upgrade
Debt / FCF Ratio
7.667.66-3.080.040.10
Upgrade
Asset Turnover
1.621.621.161.791.842.30
Upgrade
Inventory Turnover
11.2611.267.5322.888.9614.50
Upgrade
Quick Ratio
1.111.110.990.970.440.58
Upgrade
Current Ratio
1.821.821.511.390.840.98
Upgrade
Return on Equity (ROE)
16.79%16.79%24.98%66.14%71.37%40.49%
Upgrade
Return on Assets (ROA)
7.15%7.15%9.46%26.40%19.63%8.89%
Upgrade
Return on Capital (ROIC)
11.07%11.07%16.07%39.41%52.34%25.48%
Upgrade
Return on Capital Employed (ROCE)
14.10%14.10%14.50%40.30%63.30%34.60%
Upgrade
Earnings Yield
7.30%2.20%2.02%---
Upgrade
FCF Yield
0.75%0.23%-0.19%---
Upgrade
Dividend Yield
0.22%0.13%0.09%---
Upgrade
Payout Ratio
4.06%4.06%2.88%---
Upgrade
Buyback Yield / Dilution
-4.28%-4.28%30.82%-2.10%--
Upgrade
Total Shareholder Return
-4.06%-4.14%30.91%-2.10%--
Upgrade
Updated Nov 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.